More restrictive opioid prescribing guidelines were put in place in a rightful effort to stop a devastating crisis. But this sudden and dramatic change negatively impacted chronic pain patients who were managing their pain through prescription opioids given few other effective options.
How many people around you are experiencing pain on a daily basis? It's more than you might think.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Everyone agrees patients are waiting far too long to access new drugs and treatments that enhance and extend lives. Most people concerned with accelerating treatments and cures are understandably focused on the process of drug discovery, development and approval. However, a less known but equally frustrating impediment is a federally required “scheduling” under the Controlled […]
Maybe the FDA put a hidden meaning in the name of the new pain drug that everyone is worried about. When I hear “Zohydro,” I think of a boss that my son has to beat on a video game. Then I think of the multi-headed snake hydra. I did a quick search of hydra on […]
It’s time to hang out again. This month I’ll be talking with entrepreneurs who are wrangling big streams of data into manageable intelligence. We also will have a doctor in on the conversation to have a provider-centric reality check in place. You can join the conversation on the MedCity News Google + page or right […]